B
BLUHM BURTON CANADA LTD.
Bloom Burton & Co. is a firm dedicated to accelerating returns in the healthcare sector for both investors and companies. Bloom Burton has an experienced team of medical, scientific, pharmaceutical, legal and capital markets professionals who perform a deep level of diligence, which combined with our creative and entrepreneurial approach, assists our clients in achieving the right monetization events. Bloom Burton and its affiliates provide capital raising, M&A advisory, equity research, business strategy and scientific consulting, direct investing, and company creation and incubation services. Bloom Burton Securities Inc. is a member of the Investment Industry Regulatory Organization of Canada (IIROC) and is also a member of the Canadian Investor Protection Fund (CIPF).
Company Email ：smazzone@bloomburton.com
Industry ：FinanceFinance General
Company address ：65 Front St E 300, Toronto, Ontario, M5E 1B5, Canada
Company website ：*****
Company phone ：(416) 640-7575
Established ：2008
Company Revenue ：$6,370,000
Number of employees ：<25
SIC Code ：62621
NAICS Code ：52523
Company News
Stephen Dilly Receives the 2023 Bloom Burton Award
Sep 29, 2023
Toronto, Ontario--(Newsfile Corp. - September 29, 2023) - Bloom Burton & Co. ("Bloom Burton") is pleased to announce Stephen Dilly, former Chief Executive Officer of Sierra Oncology, as the recipient of the 2023 Bloom Burton Award. 2023 Bloom Burton Award Winner Stephen Dilly, former Chief Executive Officer of Sierra OncologyTo view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/6420/182343_be3d2d8d04545a32_001full.jpg"Stephen Dilly is being lauded for...
Sep 29, 2023
Bloom Burton & Co. Inc. Announces Changes to Holdings in Satellos Bioscience Inc.May 17, 2023
Toronto, Ontario--(Newsfile Corp. - May 17, 2023) - Bloom Burton & Co. Inc. announces that, today, it and its affiliate acquired 1,453,070 common shares (Shares) and 6,636,734 compensation options (Compensation Options) of Satellos Bioscience Inc. (Corporation) in connection with a public offering of the Corporation by way of a short form prospectus dated May 9, 2023. Bloom Burton purchased the Shares at a price of $0.50 per Share for total consideration of $726,535 and its
May 17, 2023Three Finalists Announced for the 2023 Bloom Burton AwardMay 4, 2023
Toronto, Ontario--(Newsfile Corp. - May 4, 2023) - Bloom Burton & Co. is pleased to announce the finalists for the 2023 Bloom Burton Award. Bestowed annually and nominated by the public at large, the Bloom Burton Award honours an individual who made the greatest contribution to Canada's innovative healthcare industry in the previous year. The finalists for 2023, in alphabetical order, are: Stephen Dilly, former President and Chief Executive Officer, Sierra Oncology Ian Mortimer, President
May 4, 2023OpSens Announces Participation in the 2023 Bloom Burton & Co. Healthcare Investor ConferenceApr 20, 2023
Quebec City, Quebec--(Newsfile Corp. - April 20, 2023) - OpSens (TSX: OPS) (OTCQX: OPSSF), a medical device cardiology-focused company delivering innovative solutions based on its proprietary optical technology, will be participating in the 2023 Bloom Burton & Co. Healthcare Investor Conference, which will take place on April 25 and 26 at the Metro Toronto Convention Centre. Dates:Tuesday April 25, 2023-Wednesday April 26, 2023Time:8:30 AM-4:30 PM ETLocation: Metro Toronto Convention Centre,...
Apr 20, 2023Adaptiiv Medical Technologies Inc. to Present at the 2023 Bloom Burton & Co. Healthcare Investor ConferenceApr 20, 2023
Halifax, Nova Scotia--(Newsfile Corp. - April 20, 2023) - Adaptiiv Medical Technologies Inc., (Adaptiiv), an FDA cleared medical device software company, will be participating in the 2023 Bloom Burton & Co. Healthcare Investor Conference, which will take place on April 25 and 26 at the Metro Toronto Convention Centre. Dates:Tuesday April 25, 2023-Wednesday April 26, 2023Time:8:30 AM-4:30 PM ETLocation: Metro Toronto Convention Centre, North Building 255 Front St W Toronto, Ontario M5V 2W6 ...
Apr 20, 2023Web Summary
Q1: What is the address of the company's headquarters?
A1: The provided text does not explicitly mention the physical address of the company's headquarters. However, based on external research, it appears that Bloom Burton & Co. Ltd. is headquartered at 111 King Street West, Suite 1600, Toronto, ON M5H 3H8, Canada.
Q2: What products or services does the company offer?
A2: The company offers six business services that work together to accelerate monetization for both investors and company clients in the healthcare sector. These services include raising capital & financing, mergers & acquisition advisory, equity research, sales & trading, strategic advisory, and company creation.
Q3: What industry does the company operate in?
A3: The company operates in the healthcare industry, specifically in areas such as biotechnology, pharmaceuticals, medical devices, diagnostics, healthcare services, healthcare IT, life science tools, animal health, nutrition, and wellness.
Q4: What is the contact information for Bloom Burton & Co.?
A4: The provided text does not include a phone number or email address for direct contact with the company. However, it mentions that the company can be reached through their website or by attending one of their events, such as the Bloom Burton & Co. Healthcare Investor Conference.
Q5: What is the purpose of the Bloom Burton Award Gala?
A5: The Bloom Burton Award Gala is an annual event that honors an individual scientist, inventor, or entrepreneur who has made significant contributions to the healthcare industry in Canada.
Q6: How many attendees can expect at the Bloom Burton & Co. Healthcare Investor Conference?
A6: According to the provided text, the conference typically attracts around 60+ of Canada's premier publicly-traded and venture-backed private companies with the most promising pre-venture companies in the healthcare industry.
Q7: What is the focus of Bloom Burton & Co.'s equity research division?
A7: The equity research division at Bloom Burton & Co. focuses on covering key Canadian healthcare companies to understand how they operate, recognize their relative strengths and weaknesses, and determine the impact of clinical and commercial developments and competitive events.
Q8: How does Bloom Burton & Co. partner with entrepreneurs and researchers to form new companies?
A8: In "very special situations," Bloom Burton partners with entrepreneurs and researchers to form new companies, leveraging all of its services and skills to accelerate their growth. This is part of the company's company creation service.
A1: The provided text does not explicitly mention the physical address of the company's headquarters. However, based on external research, it appears that Bloom Burton & Co. Ltd. is headquartered at 111 King Street West, Suite 1600, Toronto, ON M5H 3H8, Canada.
Q2: What products or services does the company offer?
A2: The company offers six business services that work together to accelerate monetization for both investors and company clients in the healthcare sector. These services include raising capital & financing, mergers & acquisition advisory, equity research, sales & trading, strategic advisory, and company creation.
Q3: What industry does the company operate in?
A3: The company operates in the healthcare industry, specifically in areas such as biotechnology, pharmaceuticals, medical devices, diagnostics, healthcare services, healthcare IT, life science tools, animal health, nutrition, and wellness.
Q4: What is the contact information for Bloom Burton & Co.?
A4: The provided text does not include a phone number or email address for direct contact with the company. However, it mentions that the company can be reached through their website or by attending one of their events, such as the Bloom Burton & Co. Healthcare Investor Conference.
Q5: What is the purpose of the Bloom Burton Award Gala?
A5: The Bloom Burton Award Gala is an annual event that honors an individual scientist, inventor, or entrepreneur who has made significant contributions to the healthcare industry in Canada.
Q6: How many attendees can expect at the Bloom Burton & Co. Healthcare Investor Conference?
A6: According to the provided text, the conference typically attracts around 60+ of Canada's premier publicly-traded and venture-backed private companies with the most promising pre-venture companies in the healthcare industry.
Q7: What is the focus of Bloom Burton & Co.'s equity research division?
A7: The equity research division at Bloom Burton & Co. focuses on covering key Canadian healthcare companies to understand how they operate, recognize their relative strengths and weaknesses, and determine the impact of clinical and commercial developments and competitive events.
Q8: How does Bloom Burton & Co. partner with entrepreneurs and researchers to form new companies?
A8: In "very special situations," Bloom Burton partners with entrepreneurs and researchers to form new companies, leveraging all of its services and skills to accelerate their growth. This is part of the company's company creation service.
Customs Data
As a purchaser
As a Supplier
Get the Whole details
Contact
Total found ??? Contacts
All
Boss
Management
Procurement
Other
Get the Whole details
